Yun Ling
Impact in
- Infectious Diseases top 0.2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- Neurology top 1%
- Long-Term Effects of COVID-19
Papers in
-
- Natural product bioactivities and synthesis 7
- Oncology 35
- Cancer Immunotherapy and Biomarkers 8
- Co-authors
- Hongzhou Lu (14 shared papers)Yuxin Shi (4 shared papers)Jun Chen (8 shared papers)Na Lu (15 shared papers)Qinglong Guo (15 shared papers)Fei Shan (3 shared papers)Jie Shen (2 shared papers)Nannan Shi (2 shared papers)
- Journals
- PLoS ONE (5 papers)Frontiers in Immunology (5 papers)Journal of Clinical Oncology (5 papers)Oncotarget (4 papers)Biomedical Chromatography (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yun Ling
255 papers receiving 9.1k citations
Yun Ling's Hit Papers
Peers
Comparison fields: 5 of 185
- Infectious Diseases 3.1k
- Neurology 1.0k
- Oncology 1.3k
- Critical Care and Intensive Care Medicine 196
- Modeling and Simulation 179
Countries citing papers authored by Yun Ling
This map shows the geographic impact of Yun Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun Ling more than expected).
Fields of papers citing papers by Yun Ling
This network shows the impact of papers produced by Yun Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun Ling. The network helps show where Yun Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Yun Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 264 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia Hit paper breakdown → | 2020 | 869 |
| 2 | COVID-19 with Different Severities: A Multicenter Study of Clinical Features Hit paper breakdown → | 2020 | 599 |
| 3 | Clinical progression of patients with COVID-19 in Shanghai, China Hit paper breakdown → | 2020 | 592 |
| 4 | Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients Hit paper breakdown → | 2020 | 564 |
| 5 | 2020 | 489 | |
| 6 | Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19 Hit paper breakdown → | 2020 | 417 |
| 7 | Uniaxial True Stress-Strain after Necking | 1996 | 250 |
| 8 | Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma Hit paper breakdown → | 2020 | 212 |
| 9 | 2007 | 211 | |
| 10 | 2020 | 197 | |
| 11 | 2010 | 169 | |
| 12 | 2020 | 130 | |
| 13 | 2013 | 98 | |
| 14 | 2020 | 90 | |
| 15 | 2007 | 89 | |
| 16 | 2008 | 85 | |
| 17 | 2010 | 78 | |
| 18 | 2016 | 75 | |
| 19 | 2015 | 73 | |
| 20 | 2017 | 71 |
About Yun Ling
Yun Ling is a scholar working on Molecular Biology, Oncology, Infectious Diseases, Pulmonary and Respiratory Medicine and Plant Science, having authored 264 papers that have together received 9.3k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (25 papers), Lung Cancer Treatments and Mutations (16 papers), SARS-CoV-2 and COVID-19 Research (13 papers), Cancer Immunotherapy and Biomarkers (8 papers), Flavonoids in Medical Research (8 papers), Advanced Photocatalysis Techniques (7 papers), Long-Term Effects of COVID-19 (7 papers) and Natural product bioactivities and synthesis (7 papers). The work is most often cited by research in Infectious Diseases (3.1k citations), Neurology (1.0k citations), Oncology (1.3k citations), Critical Care and Intensive Care Medicine (196 citations) and Modeling and Simulation (179 citations). Yun Ling has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hongzhou Lu, Yuxin Shi, Jun Chen, Na Lu, Qinglong Guo, Fei Shan, Jie Shen, Nannan Shi, Fengxiang Song and Zhiyong Zhang. Their work appears in journals such as PLoS ONE, Frontiers in Immunology, Journal of Clinical Oncology, Oncotarget and Biomedical Chromatography.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.